New nasal vaccine aims to protect kids from RSV
NCT ID NCT05655182
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 3 times
Summary
This study tests a new nasal spray vaccine (BLB-201) to prevent RSV, a common virus that can cause serious breathing problems in young children. About 137 infants and children aged 8 to 59 months will receive either the vaccine or a placebo. The goal is to check if the vaccine is safe and helps the body build protection against RSV.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AMR Newton
RECRUITINGNewton, Kansas, 67114, United States
-
Baylor College of Medicine
RECRUITINGHouston, Texas, 77030, United States
-
Be Well Clinical Studies
RECRUITINGLincoln, Nebraska, 68516, United States
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
-
Clinical Research Prime
RECRUITINGRexburg, Idaho, 83440, United States
-
Michigan Institute of Research
RECRUITINGAllen Park, Michigan, 48101, United States
-
Paradigm Clinical Research
RECRUITINGLa Mesa, California, 91942, United States
-
Paradigm Clinical Research - Modesto
RECRUITINGModesto, California, 95355, United States
-
Paradigm Clinical Research Centers, LLC - Colorado, 1550 South Potomac Street, Suite 340
RECRUITINGAurora, Colorado, 80012, United States
-
Tribe Clinical Research, LLC Parkside Pediatrics
RECRUITINGGreenville, South Carolina, 29680, United States
-
University of California, San Diego
RECRUITINGSan Diego, California, 92123, United States
-
Velocity Clinical Research - Lafayette
RECRUITINGLafayette, Louisiana, 70508, United States
-
Velocity Clinical Research, Austin
RECRUITINGCedar Park, Texas, 78613, United States
-
Velocity Clinical Research, Boise
RECRUITINGMeridian, Idaho, 83642, United States
-
Velocity Clinical Research, Cleveland
RECRUITINGBeachwood, Ohio, 44122, United States
-
Velocity Clinical Research, Grand Island
RECRUITINGGrand Island, Nebraska, 68803, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Nasal spray vaccine aims to shield children from RSV
- Inhaled interferon could be new weapon against severe RSV in young children
- New oral pill aims to fight RSV in adults
- New antiviral pill aims to shorten RSV symptoms in vulnerable adults
- New rapid test could spot flu and RSV in minutes at your local clinic
- Experimental 'Storm Stopper' therapy tested for COVID-19, flu, and RSV